(Allergan plc)

	AGN latest price $232.6045 (-1.53%) ($228.9562 - $238.1445) on Thu. Apr. 7, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.64% (three month average)
RSI	35
Latest Price	$232.6045(-1.53%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -2.1% a day on average for past five trading days.
Weekly Trend	AGN declines -4.2% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(50%)    XBI(45%)    ARKG(42%)    SPY(41%)
Factors Impacting AGN price	AGN will decline at least -1.32% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-12%)    SHY(-4%)    IPO(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.32% (StdDev 2.64%)
Hourly BBV	0 ()
Intraday Trend	-2.1%

Resistance Level	$262.34
5 Day Moving Average	$244.75(-4.96%)
10 Day Moving Average	$253.99(-8.42%)
20 Day Moving Average	$262.34(-11.33%)
To recent high	-20.5%
To recent low	1.9%
Market Cap	$76.69b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed